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Abstract 
Synthetic biology is the repurposing of biological systems for novel objectives and 
applications. Through the coordinated and balanced expression of genes, both native and 
those introduced from other organisms, resources within an industrial chassis can be siphoned 
for the commercial production of high-value commodities. This developing interdisciplinary 
field has the potential to revolutionise drug discovery from higher plants, by providing a 
diverse array of tools, technologies and strategies for exploring the large chemically complex 
space of plant natural products using unicellular organisms. In this review we emphasise the 
key features that influence the generation of biorefineries and highlight technologies and 
strategic solutions that can be used to overcome engineering pitfalls with rational design. Also 
presented is a succinct guide to assist the selection of unicellular chassis most suited for the 
engineering and subsequent production of the desired natural product, in order to meet the 
global demand for plant natural products in a safe and sustainable manner. 
 
Highlight: 
Synthetic biology provides tools for exploring the chemical space of plant natural products, 
thereby revolutionising drug discovery. A suite of unicellular organisms can be used as 
production chassis. 
 
Keywords: promoter engineering, protein engineering, biosensor, genome reduction, non-
canonical bacteria, non-canonical yeast, cyanobacteria, microalgae 
 
Running Title: Synbio for plant metabolites in unicellular organisms 
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Introduction 
Synthetic biology is an evolving field that is emerging as a centrepiece of rational biological 
design. It is an interdisciplinary science that combines the expertise of biologists, engineers, 
physicists and computer scientists to gain in-depth understanding of the functioning of living 
systems, thereby allowing their (re)design for novel purposes, such as to be utilised for the 
sustainable production of biomolecules, biomaterials, and fine and bulk chemicals. A 
relatively older field in biology, that involves the optimisation of genetic and regulatory 
processes within cells to increase the production of certain compounds of interest, is 
metabolic engineering. As research publications in the field increase, there is an ever-growing 
misuse of the terminologies of synthetic biology and metabolic engineering (Stephanopoulos, 
2012). Before we go further into the implications and applications of synthetic biology, we 
will define and distinguish the concepts of metabolic engineering and synthetic biology. 
Metabolic engineering in its simplest definition is the directed modification of 
metabolic pathways in a living organism for the synthesis of a desired product. It 
encompasses the compilation of pathway genes ultimately to yield product in a high titre, high 
production rate and efficient manner. Optimisation of the production host with flux balancing 
involves coordinating both cell and heterologous pathway performance. While the 
construction and generation of engineered strains may take only a short time, improving these 
to the point of use for commercial production is likely a much more time-consuming process. 
In this context, the core enabling technology of synthetic biology can aid metabolic 
engineering (Stephanopoulos, 2012). The two fields overlap partially in their interest of 
pathway engineering, but synthetic biology is characterised by the use of defined ‘parts’ that 
are easily combined and exchanged, using standardised workflows and often combined with 
modelling and computational methods, with the aim to take advantage of high-throughput 
methodology such as robotics (Fig. 1). This may be extended to synthetic cells, genetic 
circuits and non-linear cell dynamics for the generation of novel gene networks and whole 
genome synthesis. However, developments in both metabolic engineering and synthetic 
biology strategies provide complementary methods to improve the in vivo performance of 
cells, in particular industrial microorganisms (Awan et al., 2016; Keasling, 2012; Lechner et 
al., 2016; Stephanopoulos, 2012). 
Synthetic biology is reorienting and revolutionising drug discovery from plants, a 
major source of human medicine and high-value compounds (Frasch et al., 2013). Higher 
plants produce and accumulate a diverse array of small molecules (referred to as plant natural 
products, secondary or specialised metabolites) that are most often not essential for their 
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fundamental physiological processes, but contribute greatly to their ecology. Humans have 
exploited the therapeutic potential of many natural products in the form of traditional herbal 
medicine, and more recently popularised them as flavours, fragrances, colorants and health 
promoting agents. Based on their chemical structure and biosynthetic origin, the plant natural 
products are classified into three major classes, the terpenoids, alkaloids and phenolics 
(Croteau et al., 2000). The chemical complexity of these compounds and their scarce 
production in the plants themselves has stimulated efforts to introduce their biosynthetic 
pathways into heterologous organisms. Microbial systems offer many advantages because 
these have rapid doubling times, are robust under process conditions, are readily scalable, and 
have extensive engineering toolkits. In addition, they offer a simplified product purification 
pipeline owing to the lack of competing contaminants, and most of all make the production 
process cost-effective by converting inexpensive feedstock to high value compounds. The 
success with metabolic engineering for the production of the anti-malarial drug artemisinin in 
yeast and E. coli set the dawn for synthetic biology for the production of plant natural 
products in cellular factories (Paddon and Keasling, 2014). Today microbial cells are widely 
used as production systems, as well as screening platforms for target chemical production. 
Furthermore, synthetic cells have been engineered with genetic circuits to decipher disease 
mechanisms, drug mode of action mechanisms and to study cell-to-cell communication within 
bacterial consortia (Trosset and Carbonell, 2015). 
Plant natural products are often synthesised by the action of multiple enzymes: 
artemisinin biosynthesis from the central precursor farnesyl pyrophosphate requires the 
catalytic action of four enzymes, a sesquiterpene synthase (amorpha-4,11-diene synthase, 
ADS), a cytochrome P450 monooxygenase (CYP71AV1), an alcohol dehydrogenase 
(ADH1), and an artemisinic aldehyde dehydrogenase (ALDH1) (Covello, 2008). To produce 
a plant natural product in a heterologous host, balancing the expression of all pathway genes 
within a host cell is critical and vital. It is also essential to acknowledge the burden caused by 
the expression of the introduced biosynthetic pathway enzymes, which not only siphons 
resources from the host’s native pathways, but also may generate toxic pathway intermediates 
(Keasling, 2012). Synthetic biology tools that allow finely-tuned multi-gene expression, 
rational engineering of heterologous proteins in the context of the production chassis, 
quantitative uncomplicated visual screens for the target chemical, and reduction of the 
metabolic burden on the host through the elimination of non-essential genetic elements, are 
reviewed here as strategies that will become increasingly relevant for the engineering of smart 
cell factories (Fig. 2). In addition, computational modelling is a valuable approach to 
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synthetic biology as it allows evaluating possible cellular designs for a desired outcome by 
combining well characterised cellular modules (Kaznessis, 2009). While synthetic biology 
aspires to implement modelling for the production of natural products, thus far computational 
systems biology has only been effectively applied for the production of precursors and 
cofactors valuable for natural product biosynthesis in the widely used chassis Escherichia coli 
(Maia et al., 2015) and Saccharomyces cerevisiae (Mustacchi et al., 2006), and is starting to 
be applied in cyanobacteria (Westermark and Steuer, 2016) and algae (Perez-Garcia et al., 
2016). In this review we also bring to the spotlight several rising chassis with desirable 
characteristics for biorefinery, including non-canonical bacteria, yeasts and photosynthetic 
algae. This review provides a road map of the latest synthetic biology tools available for 
consideration and showcases the hosts available for rational engineering of high-value plant 
natural products in unicellular microbes. 
 
Microbial Cell Factories 
The biotechnological production of compounds ranging from small aromatics to more 
complex plant specialised metabolites has been achieved in microbial cell factories (Wang et 
al., 2016). Microbial fermentation regularly forms the core of the biorefinery by converting 
the often inexpensive raw material to the desired chemicals, thus providing added value. Over 
the years, E. coli and S. cerevisiae have stood out as the workhorses of biotechnology (Fig. 3) 
and continue to be engineered as cell factories for new biorefineries (Wang et al., 2016). 
However, in the evolving era of biotechnology many other unicellular microbes are being 
explored as chassis for the production of plant metabolites. Here we highlight some of their 
key features and present success stories of engineered microbial cell factories. 
 
The canonical hosts: Escherichia coli and Saccharomyces cerevisiae 
Escherichia coli is the most widely used prokaryotic host for the production of heterologous 
metabolites, owing to its rapid growth, high product yield, cost-effective nature and ease of 
scale-up. The availability of various expression vectors and strains, manipulation 
technologies, and the relative ease of product purification make it an attractive host for 
industrial applications. However, the lack of intracellular membranes and absence of 
posttranslational modifications limit its use as the chassis of choice for many plant natural 
products. Nonetheless, technological advancements to meet industrial requirements have 
resulted in the use of E. coli for the production of a range of complex plant specialised 
metabolites, including flavonoids (Katsuyama et al., 2007) and its glycosides (Kim et al., 
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2015), mono- (Jongedijk et al., 2016; Tashiro et al., 2016), sesqui- (Han et al., 2016; Yang 
and Nie, 2016), di- (Biggs et al., 2016) and tetraterpenoids (Li et al., 2015; Ma et al., 2016), 
as well as alkaloid precursors such as (S)-reticuline (Matsumura et al., 2017) and geraniol 
(Chen et al., 2016). 
Similarly, the well-known baker’s yeast Saccharomyces cerevisiae has been the 
eukaryotic host of choice, since it is fermentable, genetically tractable and generally 
recognised as safe (GRAS). Moreover, it is more effective than E. coli in expressing genes 
coding for membrane-bound cytochrome P450 monooxygenases (P450), which are key 
catalysts in several plant specialised metabolite pathways, although yeasts require the 
coexpression of plant P450 reductase genes for optimal electron delivery to the P450 enzyme 
(Werck-Reichhart and Feyereisen, 2000). Thus far many plant specialised metabolite 
pathways have been successfully reconstituted in yeast for the production of flavonoids and 
stilbenoids (Billingsley et al., 2016), a variety of alkaloids (Kishimoto et al., 2016), 
polyketides (Bond et al., 2016), terpenoids (Brown et al., 2015; Paddon and Keasling, 2014), 
and aromatic amino acid derived compounds such as muconic acid (Suastegui and Shao, 
2016). Yeasts have been employed to refactor biosynthetic pathways, optimise production and 
industrially scale-up engineered organisms using genomic, synthetic biology (Fig. 1) and 
metabolic engineering (Fig. 3) strategies. Despite the many advantages (Fig. 4; Billingsley et 
al., 2016), S. cerevisiae can be a challenging host to engineer, as some proteins prove to be 
non-functional or show low activity. In addition the native spliceosome activity of yeast is 
poor, which requires the removal of introns from heterologous protein coding sequences 
before introduction into this host. These features can result in poor precursor supply or sub-
optimal flux through the heterologous pathway, leading to low titres of the product 
(Billingsley et al., 2016; Kavscek et al., 2015). 
 
Non-canonical bacterial hosts: Bacillus subtilis, Corynebacterium glutamicum and 
Pseudomonas putida 
The expansion of synthetic biology from traditional chassis to other organisms depends 
primarily on the biotechnological application that is desired. This has led to the identification 
of production hosts with fast growth, well-characterised regulation and the possibility to 
engineer using known metabolic networks. 
Bacillus subtilis is a GRAS organism with a fast growth rate that has been extensively 
used for the industrial production of proteins. It has a wide substrate utilisation range, can 
survive under harsh conditions and produces innate cellulases that can degrade lignocellulosic 
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material to generate cheap carbon source for large-scale industrial fermentations. It has drawn 
tremendous attention because of its high isoprene production rate, making it theoretically an 
ideal host for terpenoid biosynthesis (Julsing et al., 2007; Wagner et al., 2000). It has been 
successfully used for the engineering of the sesquiterpenoid amorpha-4,11-diene, the 
precursor of artemisinin (Zhou et al., 2013). However, B. subtilis, like all Gram-positive 
bacteria shows plasmid instability, and being incompletely characterised poses engineering 
challenges. Despite these shortcomings, a genome-reduced strain of B. subtilis was generated 
and used for the production of heterologous enzymes (Juhas et al., 2014; Li et al., 2016). Also 
the strengths of promoter candidates that can be used for transgene expression were evaluated 
recently in B. subtilis (Song et al., 2016). These studies allow a deeper understanding of the 
host and facilitate future work to develop this organism as a production strain using synthetic 
biology approaches. 
 Corynebacterium glutamicum is a pigmented Gram-positive bacterium, which has 
been extensively used for the industrial production of amino acids. It also naturally 
synthesises the cyclic carotenoid decaprenoxanthin and its glucosides, which makes it a 
potential chassis for the engineering of plant terpenoids such as the carotenoids β-carotene 
and zeaxanthin (Heider et al., 2014), and the sesquiterpenoid (+)-valencene (Frohwitter et al., 
2014). Through engineering of the isoprenoid pathway and co-expression of plant genes, 
lycopene and astaxanthin production in C. glutamicum was reported in a genome-reduced 
strain (Baumgart et al., 2013; Heider and Wendisch, 2015). 
 Pseudomonas putida is a Gram-negative soil bacterium traditionally known for its 
xenobiotic degradation activity. Like B. subtilis and C. glutamicum, refactored P. putida 
strains with streamlined genomes were observed to outperform the wild-type strain in 
heterologous protein production (Lieder et al., 2015). These bacteria are readily adaptable to 
selective pressures, can relatively easily develop resistance to drugs, and have multiple efflux 
pumps that contribute to their resistance to toxic compounds, making them good candidates 
for directed evolution experiments with the aim of producing specialised chemicals through 
synthetic pathway expression. P. putida strains are also well known for their ability to cope 
with high oxidative stress and in the process to generate high concentrations of reducing 
equivalents, which are advantageous for the synthesis of several plant specialised metabolites 
(Kim et al., 2016). In addition to these natural advantages, molecular biology tools, such as 
inducible promoter systems and fully sequenced genomes of P. putida strains allow 
manipulation and thus boosting of the metabolic capabilities of this host as a microbial 
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factory. P. putida has been used as a production host for rhamnolipids, terpenoids, polyketides 
and non-ribosomal peptides (Loeschcke and Thies, 2015). 
 
Non-canonical yeast hosts: Yarrowia lipolytica, Pichia pastoris, Hansenula polymorpha and 
Kluyveromyces lactis 
Yarrowia lipolytica is a dimorphic, non-pathogenic and strictly aerobic GRAS yeast with 
promising properties to be utilised as a host for engineering the production of plant 
specialised metabolites, particularly because of its oleaginous nature (Markham and Alper, 
2015). Several engineering tools have been developed in this host with the aim of utilising it 
for industrial production of valuable compounds; including an efficient transformation 
method (Yu et al., 2016), gene editing and insertion into specific genomic loci with CRISPR-
Cas9 (Gao et al., 2016a; Schwartz et al., 2016), expansion of the substrate range to utilise 
sugars that are abundant in lignocellulosic hydrolysates as a carbon source (Ledesma-Amaro 
et al., 2016; Ledesma-Amaro and Nicaud, 2016), and the identification of genetic elements 
(promoters, terminators, etc.) for efficient gene expression (Blazeck et al., 2013; Curran et al., 
2015; Shabbir Hussain et al., 2016). With these tools Y. lipolytica has been engineered for the 
production of metabolites such as β-carotene and aromatic compounds (Gao et al., 2014; Liu 
et al., 2015). 
 Pichia pastoris is a methylotrophic yeast reputed for the industrial production of 
biopharmaceutical proteins, humanised glycoproteins in particular (Vogl et al., 2013). It can 
typically achieve high-density fermentations, is tractable to genetic modifications and has 
highly evolved pathways for posttranslational protein modification. Besides being extensively 
used for protein production, P. pastoris has recently gained attention as a platform cell factory 
for pathway engineering, which has led to advancements in molecular and genome 
engineering toolboxes for this host (Kang et al., 2017; Vogl et al., 2014). The production of 
xanthophyllic compounds astaxanthin, lycopene, β-carotene and canthaxanthin was 
successfully engineered into P. pastoris (Araya-Garay et al., 2012). 
 Like P. pastoris, Hansenula polymorpha has been extensively used for humanised 
glycoprotein engineering. It is a methylotrophic, thermotolerant yeast that can utilise glucose 
and xylose for ethanol fermentation at temperatures up to 50°C (Suwannarangsee et al., 
2010). H. polymorpha also possesses tightly-regulated native promoters, which are a useful 
asset in synthetic pathway engineering (Saraya et al., 2012). Krasovska and co-workers 
reported a glucose repression-deficient H. polymorpha strain in which genes can be induced 
with methanol in the presence of glucose. This lack of glucose repression is particularly 
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interesting as the strain can be cultured in an inexpensive glucose-based medium containing a 
minimal inducing concentration of methanol, instead of an induction medium with high-
concentration of methanol as the primary carbon source (Krasovska et al., 2007). Thus far 
plant natural product biosynthesis has not been engineered in H. polymorpha, but it has been 
successfully implemented for the production of the plant fatty acid γ-linolenic acid (Khongto 
et al., 2010). 
 Kluyveromyces lactis is the most similar in native biosynthetic capacities to S. 
cerevisiae and often promoters and toolkits from the latter are used for heterologous gene 
expression in the former. K. lactis also has tightly-regulated native promoters. In addition, 
there is a high level of transferability in vectors for K. lactis, but they have low stability in the 
host and are lost over a few generations compared to S. cerevisiae (Rodicio and Heinisch, 
2013). 
Each of these non-conventional yeasts present different advantages, commonalities, 
and differences compared with S. cerevisiae and has been concisely summarised elsewhere 
(Wagner and Alper, 2016). In short, each has diverse catabolic repertoires which enables low 
cost bioprocesses, can produce high levels of heterologous proteins and are ‘Crabtree-
negative’ as they do not undergo aerobic alcoholic fermentation, unlike S. cerevisiae. 
Nonconventional host systems like the organisms listed above require an expanded synthetic 
biology toolkit to compete with the well-established conventional production hosts. Highly 
controllable, programmable and tuneable expression cassettes, targeted recombination and 
metabolic engineering strategies for multi-gene pathway expression need to be developed and 
implemented in these hosts for their future application in synthetic biology. 
 
The photosynthetic cell factories 
Cyanobacteria and microalgae are a diverse group of aquatic, unicellular photosynthetic 
microorganisms that have been used as models to study fundamental biological processes 
(Dorrell and Smith, 2011). Their unicellular physiology, rapid cell division (doubling time of 
5-8 hours in Chlamydomonas and 4-12 hours in cyanobacteria) and photosynthetic growth 
render them ideal for the production of a plethora of compounds, including specialty 
chemicals, pharmaceuticals, food supplements and biofuels. In part, algal biotechnology has 
been stimulated by the natural capacity of these organisms to synthesise and store compounds 
of commercial interest, including high-value products such as pigments, vitamins and 
antioxidants, and bulk compounds like glycerol and triacylglycerols with potential as biofuels 
(Gimpel et al., 2015). Furthermore, they inhabit diverse aquatic and terrestrial environments, 
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adopting photosynthetic, heterotrophic and mixotrophic lifestyles. Therefore, unlike crop-
based industries, large-scale cultivation of these organisms does not require precious arable-
land (Pittman et al., 2011), high water usage (Yang et al., 2011), and input such as fertilisers 
(Yang et al., 2011; Scaife and Smith, 2016). 
 Cyanobacteria and microalgae are suitable industrial biotechnology platforms (Fig. 4), 
since like bacteria and yeast they can be grown at scale in controlled and contained 
environments. However, being photosynthetic and being able to fix carbon from inorganic 
sources, their cultivation is in principle more sustainable than that of heterotrophic chassis, 
nonetheless to be certain it is essential to carry out life cycle assessment for any particular 
process (Kazamia and Smith, 2014). Before cultivation of engineered strains is possible on the 
very large scales needed for economically profitable production however, many challenges 
have to be overcome (Klein-Marcuschamer et al., 2013; Scaife and Smith, 2016; Scott et al., 
2010). Although these challenges can be addressed with the current genetic and molecular 
toolkits, the adoption of synthetic biology principles can accelerate the cumbersome process 
of strain development and optimisation (Fig. 1). To this end, current engineering technologies 
of photosynthetic cells need to be upgraded and new tools developed to ultimately produce 
economically competitive cyanobacterial- and algal-sourced biochemicals. 
 
Cyanobacteria as hosts 
There are over 100 cyanobacterial species with sequenced genomes, and technical and 
practical knowledge are enabling metabolic engineering of many of them. Four hosts in 
particular are widely exploited – Anabaena sp. PCC 7120, Synechocystis sp. PCC 6803, 
Synechococcus sp. PCC 7002 and Synechococcus sp. PCC 7942. Indeed, proof-of-principle 
metabolic engineering involving directed tailoring of native metabolism, or introduction of 
heterologous metabolic pathways, has been reported for a range of platform chemicals such as 
2,3-butanediol, lactate, more specialist molecules like limonene and even potential biofuel 
molecules such as ethanol and isoprene (Table 1). These examples of metabolic engineering 
used classic genetic engineering approaches for the introduction of gene(s). The trial and error 
nature of selection and use of DNA parts (e.g. promoters, transgenes, terminators) and 
methodologies (e.g. optimisation for codon usage) consistently resulted in slow strain 
development and suboptimal outcomes, that can be particularly unpredictable when combined 
with the occurrence of genetic instability (Jones, 2014). For example, the first report of the 
heterologous expression of an isoprene synthase (IspS) gene in Synechocystis sp. PCC6803 
(Lindberg et al., 2010) resulted in trace levels of isoprene, a C-5 hydrocarbon that serves as a 
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feedstock for the rubber industry (Lindberg et al., 2010). To boost isoprene production, codon 
optimisation increased IspS expression by 10-fold, while heterologous expression of the 
mevalonate pathway in Synechocystis improved pathway intermediate abundance, which in 
turn increased isoprene production by 2.5-fold (Bentley et al., 2014). These improvements 
were still impeded by metabolic bottlenecks, which were elucidated and additional IspS 
enzymes from different organisms were tested for activity and product yield, allowing rational 
metabolic engineering to produce 0.54 g gDW-1 isoprene in Synechococcus sp. PCC7942 
(Gao et al., 2016b). The journey to engineer isoprene-producing cyanobacteria has 
highlighted the slow and time-consuming nature of current approaches towards engineering of 
a simple pathway that yields a simple molecule. It is therefore not surprising that a synthetic 
biology approach that combines rational design with systems-level analysis of impact upon 
introduction of heterologous genes would have the greatest impact on the speed and efficiency 
of the engineering of multi-step pathways that produce complex molecules like triterpenoids. 
Recently, synthetic biology approaches have been adopted for engineering of cyanobacteria 
with P450s, where requirement for reducing equivalents were met by plastidic non-cognate 
redox partners, photoreduced ferredoxin and flavodoxin (Gnanasekaran et al., 2015; Goñi et 
al., 2009; Lassen et al., 2014; Wlodarczyk et al., 2016). This novel strategy for re-routing 
electron partitioning allows engineers to overcome the bottleneck of insufficient reducing 
power, and design P450-dependent pathways to tap into the ample supply of reducing power 
of photosynthetic organisms (Nielsen et al., 2016). Looking to the future of synthetic biology, 
inspiration can be drawn from work in E. coli, where systems-level analysis informed by 
genome-scale models for flux-balance analyses (Chubukov et al., 2016) are proving vital for 
production of metabolites at a commercial scale. Therefore the potential for similar genome-
scale models, now available for Cyanothece sp. ATCC 51142, Synechococcus sp. PCC 7002, 
and Synechocystis sp. PCC 6803 (Knoop et al., 2013; Nogales et al., 2012; Vu et al., 2012), 
cannot be overstated. 
 
Microalgae as hosts 
Compared with cyanobacteria, fewer microalgal genomes have been fully sequenced and 
annotated. Despite this, a wide range of microalgae has been genetically engineered, although 
it is routine only for a few species (Table 1). A particular issue for microalgae is that currently 
nuclear transformation is by random integration. Although homologous recombination has 
been reported for a few species, such as Ostreococcus and Nannochloropsis, this is not 
routine, and moreover is not possible in the most widely used algal hosts such as 
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Chlamydomonas reinhardtii and Phaeodactylum tricornutum. A further complication in C. 
reinhardtii is extensive transgene silencing. Strains of this green alga, UVM4 and UVM11, 
identified from a UV mutagenized population, due to their propensity for increased transgene 
expression (Neupert et al., 2009), are helping to overcome this issue. 
Another issue among microalgae is to improve the efficiency of transformation and 
overcome complications of DNA fragmentation caused by biolistics and electroporation. To 
this end, Karas and co-workers have developed extrachromosomal vectors or episomes for 
transgene expression in P. tricornutum (Karas et al., 2015). Coupled with a conjugation 
method for transfer of the construct assembled in E. coli directly to diatom cells, 
transformation frequency has been markedly improved in this species. Of wider interest is the 
utility of episomes for effective transformation of another diatom species Thalassiosira 
pseudonana (Karas et al., 2015). 
In addition to nuclear transformations, in photosynthetic organisms the chloroplast 
genome is also amenable to genetic manipulation (Manuell et al., 2007). The chloroplast 
genomes of >20 species are now accessible to genetic modification (Day and Goldschmidt-
Clermont, 2011). Being the site of major anabolic pathways (e.g. carotenoid and fatty-acid 
biosynthesis), from an engineering perspective the ability to engineer this cellular 
compartment is of significant biotechnological importance, and the methodology is well 
established for several higher plants (Bock, 2015). Similarly, the C. reinhardtii chloroplast 
has been widely manipulated but to date chloroplast transformation is not routine for any 
other microalga (Purton et al., 2013). Compared with nuclear transformations, transformation 
of the chloroplast genome for transgene expression provides unique advantages, most 
importantly the ability to target transgene insertion via homologous recombination. In 
addition, high-level expression of transgene and compartmentalised over-accumulation of 
proteins containing disulphide bonds occur readily and undesired glycosylations are prevented 
(Tissot-Lecuelle et al., 2014). Moreover, well-established bacterial resources have been 
demonstrated to function in the C. reinhardtii chloroplast, including the aadA antibiotic 
resistance marker (Goldschmidt-Clermont M, 1991), the β-glucuronidase reporter (Ishikura et 
al., 1999), and the lac repressor system (Kato et al., 2007). Given that many native promoters 
are under strict regulation of essential photosynthetic processes, access to bacterial regulatory 
resources is particularly invaluable. Analogous to cyanobacteria, re-routing of electron 
partitioning has also been successfully performed in Chlamydomonas, where transplastomic 
expression of P450 reductase and a bifunctional cis-abienol synthase resulted in the 
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translocation of these enzymes into the chloroplast and production of cis-abienol, a precursor 
used in the perfume industry (Gangl et al., 2015; Nielsen et al., 2016; Nielsen et al., 2013). 
 
Synthetic biology approaches for engineering unicellular cell factories 
Our growing understanding of the molecular basis of biological functions has permitted the 
engineering of biological systems for novel purposes. Modern genetics, molecular, structural, 
systems and microbiology tools have facilitated the rational engineering of natural systems, 
the unicellular microbes in particular. Understanding relationships between biomolecule 
structure and function allows the design of novel nucleic acid and protein sequences, 
incorporating non-canonical building blocks and thus assembling fully artificial systems with 
customised properties (Marner, 2009) based on the principles of synthetic biology. In this 
section we discuss the most promising technologies that are valuable for organism 
engineering (Fig. 2). 
 
Standardising parts and assembly approaches 
Well-established systems that enable targeted, temporal and spatial expression of endogenous 
and heterologous transgenes are at the forefront of synthetic biology driven engineering of 
microorganisms. The fundamental concept requires the use of standard parts that are readily 
assembled and easily interchanged, for engineering a particular organism, but ideally also 
between organisms for orthogonality (Scaife and Smith, 2016). For E. coli and yeast hosts 
knowledge and tools have been amassed over decades. Unicellular photosynthetic organisms 
such as cyanobacteria and microalgae are fast growing and can be cultured in a similar 
fashion to bacteria and yeast, and taking a synthetic biology approach now will facilitate their 
development as production platforms. In contrast, the slow generation time of higher plants 
can hamper advanced metabolic engineering, and so one approach would be to use the 
unicellular photosynthetic hosts for the generation and testing of plant DNA parts and 
technologies that can ultimately be adopted for use in higher plant biotechnology. Indeed 
advanced molecular biology techniques such as ZFN, TALENs and CRISPR/Cas9 have been 
developed, tested and optimised for many unicellular photosynthetic organisms. Examples of 
advances towards molecular tool-optimisation are many and reviewed elsewhere (Jinkerson 
and Jonikas, 2015; Scaife and Smith, 2016). 
Nonetheless, in all cases the development of standardised DNA parts that adhere to a 
common syntax for rapid assembly is revolutionising the design and building of complex 
multi-gene heterologous pathways. The first of these was BioBricks, developed by the iGEM 
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competition (Knight, 2003), where the use of specific restriction enzymes at the end of each 
part enabled them to be assembled sequentially into longer and longer sequences. This was 
followed rapidly by Gibson assembly (Gibson et al., 2009), which avoids the introduction of 
scars between the parts, and also enables several fragments to be assembled simultaneously. 
Further refinement came from methods such as Golden Gate (Engler et al., 2008), which 
combined the ease of restriction-based cloning and simultaneous, seamless assembly of 
multiple parts. 
Although the DNA parts that make up a genetic circuit may vary between organisms, 
through adoption of a syntax such as that proposed for Modular Cloning using Golden Gate 
assembly, libraries of synthetic parts are being developed and made available (Engler and 
Marillonnet, 2014; Lee et al., 2015; Patron, 2014; Weber et al., 2011). Access and ease by 
which expression cassettes can be designed and assembled, is enabling high throughput 
systematic testing of parts in the target organisms. In many instances, however the desired 
“fully predictable” parts have yet to be discovered. Indeed, successful metabolic engineering 
depends on expression of a transgene in a predictable fashion so as to modify metabolism 
reliably. Tightly regulated and inducible protein synthesis are important determinants of 
product yield, and help avoidance of unintended effects on endogenous metabolism that can 
culminate in pleiotropic defects.  
 
Regulation of transgene expression by modular effectors  
Metabolic flux in a cell is regulated by a series of interwoven regulatory controls, at the levels 
of transcription, translation, protein stability, and enzyme activity. In bacterial systems 
transcriptional regulation is probably one of the most important processes, and in a synthetic 
biology context, this may be the simplest access point to alter cellular flux. Accordingly, 
metabolic engineering efforts have long relied on the discovery and characterisation of 
effective promoters, in both bacterial and eukaryotic systems. More recently, other regulatory 
elements such as riboswitches are being employed as modular effectors that can be easily 
permuted with the coding sequence and other parts of the transcriptional units that are 
engineered into the host chassis (Berens et al., 2015; McKeague et al., 2016). 
Selecting promoters is a key component of the design cycle, where a wide range of 
expression capacities of several orders of magnitude is required for the optimal expression of 
genes in a pathway. Over the years several naturally existing promoters have been 
characterised in several bacterial and yeast hosts, but they do not represent the dynamic range 
required for flux optimisation in a pathway. Promoter engineering aims at modulating the 
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transcriptional capacity of an existing promoter by altering its DNA sequence to generate 
synthetic promoter libraries. To achieve this, natural promoters are classically subjected to 
molecular approaches such as saturation mutagenesis of promoter regions (Hammer et al., 
2006; Solem and Jensen, 2002), error-prone PCR (Hammer et al., 2006; Hauk et al., 2016; 
Reed et al., 2012; Tyo et al., 2011) or hybrid promoter engineering (Blazeck et al., 2012; 
Blazeck et al., 2011; Blazeck et al., 2013; Xu et al., 2014), and the resulting promoter variants 
are screened with quantifiable read-outs to define promoter strengths. However, this approach 
is only applicable to relatively short promoter sequences and for certain experimental 
purposes. Computational methods on the other hand allow prediction of promoter activity 
prior to functional characterisation, thereby reducing the number of promoter variants to be 
tested in vivo. In silico models like the position weight matrix (Sinha, 2006), partial least 
squares regression (Jonsson et al., 1993), and artificial neural networks (Meng et al., 2013) 
allow elucidating the effect of individual DNA bases and motifs on promoter activity. 
 In addition to validating novel promoter engineering strategies and defining promoter 
strengths, the synthetic promoters are also successfully implemented for natural product 
biosynthesis. In E. coli, a single promoter containing three unique cis-regulatory elements that 
can recognise three transcription factors simultaneously was developed using an in silico 
optimisation algorithm, to allow multiple environmental signals to modulate gene expression 
differently (Amores et al., 2015). Through a promoter engineering approach, the production 
of lycopene in E. coli was improved by modulating the expression of heterologously 
expressed genes (Shen et al., 2015). In S. cerevisiae, synthetic promoters inducible by low pH 
were engineered from pH-unresponsive promoters (Rajkumar et al., 2016). Inducible and 
constitutive synthetic minimal promoters <120bp in length, have been designed by combining 
a short robust and generic core element with strong upstream activating sequences of ~10bp 
(Redden and Alper, 2015). In a distinct approach, nucleosome architecture was used to predict 
high activity promoters computationally. As nucleosome occupancy along arbitrary DNA 
sequences is predictive, promoters can be (re)designed for defined activity (Curran et al., 
2014). Recently, a modular synthetic multi-gene promoter and transcription factor system 
consisting of adjustable and predictable expression levels ranging from negligible to very 
strong, independent from externally added inducers, was also developed for multiple gene 
pathway expression (Rantasalo et al., 2016). 
Similarly, in microalgae such as C. reinhardtii, decades of research have elucidated 
several fundamental processes that may be built upon to facilitate transgene expression 
(Scaife and Smith, 2016). Characterised promoters used for controlled transgene expression 
16 
 
include those regulated by light (Fischer and Rochaix, 2001), nitrate (Ohresser et al., 1997), 
copper (Quinn and Merchant, 1995), nitrogen (Matthijs et al., 2016) and vitamin B12 
(Helliwell et al., 2014). In addition to high-expression native promoters (e.g. RuBisCo small 
subunit gene RBCS2 and PsaD), the development and use of synthetic promoters (e.g. heat 
shock protein 70A promoter fused to the RBCS2 promoter) for constitutive expression of 
transgenes has resulted in significant improvement in the frequency of stable transformants 
obtained (Schroda et al., 2000). 
 In addition to promoters, functional non-coding RNA molecules known as 
riboswitches have been developed as synthetic regulatory elements in many bacteria and 
eukaryotes (Roth and Breaker, 2009). In general, the ligand-sensing domain (aptamer) of 
riboswitches is combined with a regulatory domain, or expression platform, which can control 
gene expression in a variety of ways. For example, in bacteria direct binding of a specific 
ligand to the aptamer domain can be used to attenuate transcription termination or translation 
initiation (Roth and Breaker, 2009), whereas in eukaryotes (plants, fungi as well as algae), 
ligand binding causes alternative splicing, which prevents protein production for example by 
introduction of an in-frame stop codon. In terms of practicality for large-scale application, the 
riboswitches can be regulated by nanomolar concentrations of ligand (Croft et al., 2007; 
Moulin et al., 2013). In C. reinhardtii, the riboswitch within the THI4 gene of the thiamine 
biosynthesis pathway has already been developed into a transgene expression regulatory tool 
(Croft et al., 2007; Moulin et al., 2013). This system has also been adapted into a novel 
synthetic regulatory circuit to regulate the expression of plastid genes (Ramundo et al., 2013). 
Riboswitches have also been developed as tools for the regulation of gene expression in 
cyanobacteria. A theophylline-dependent riboswitch has been shown to act as a stringent 
inducible protein production system in S. elongatus PCC 7942, able to achieve binary on/off 
expression states (Nakahira et al., 2013). Similar to other riboswitch systems, the level of 
protein production can be fine-tuned with different theophylline concentrations, an attribute 
that highlights the flexibility of such expression platforms when integrated within genetic 
circuits. 
 
Protein engineering 
Natural proteins and enzymes are often engineered to meet the rigorous needs of industrial 
processes. It is also a powerful tool for synthetic biology where tailored protein properties suit 
the requirements of synthetic metabolic networks. Protein engineering is a form of synthetic 
biology that contributes significantly to metabolic engineering by improving enzymatic 
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activity, altering the substrate and product specificity of enzymes, managing metabolic flux 
using enzyme scaffold engineering, and by modulating the regulatory elements that tune 
protein levels (Foo et al., 2012; Li, 2012; Li and Cirino, 2014). A key factor in protein 
engineering is the ability to precisely determine the three-dimensional structure of proteins, as 
they provide essential details about biological function and mechanism of action. 
Computational techniques aid understanding relationships between structure and function of 
proteins, which subsequently allow the modelling and design of primary amino acid 
sequences that will ultimately result in novel or modified enzyme functions. Computer-aided 
protein modelling and designing approaches, using either homology-based or ab initio 
methods, have been summarised elsewhere (Kelchtermans et al., 2014; Khan et al., 2016; 
Kingsley and Lill, 2015; Wei and Zou, 2016). 
 Directed evolution is a powerful tool for engineering proteins. Randomised variants of 
a gene encoding a protein of interest are expressed in a suitable host and combined with an 
appropriate screening method to identify mutant proteins with desired properties. With this 
approach, properties of proteins have been redesigned or improved through iterative cycles of 
mutagenesis, and amplification of the desired mutants to accumulate beneficial mutations in 
the final protein (Cobb et al., 2013). With regards to plant specialised metabolism, several 
classes of enzymes have been engineered for modulating their catalytic efficiency, specificity 
and/or activity. One such class of enzymes is the plant uridine diphosphate-dependent 
glycosyltransferase (UGT) family, the members of which catalyse the addition of sugar 
residues to natural product structures such as flavonoids or alkaloids. Glycosylation plays a 
key role in enhancing solubility and stability of specialised metabolites in the aqueous 
environment of a cell, as well as detoxification, thus facilitating their accumulation and 
storage (Liang et al., 2015). Advancements in plant UGT structural studies has bettered our 
understanding of catalytic mechanisms, which in turn allowed directed engineering for 
enhanced activity, altered regiospecificity and glycosylation pattern, to produce a plethora of 
bioactive glycosides (Wang, 2009). P450 enzymes are another superfamily that play critical 
roles in plant specialised metabolite biosynthesis. They display a wide substrate range and 
catalyse a diverse array of chemical transformations. Their ability to introduce oxygen atoms 
stereo- and regio-specifically into complex molecules, and to activate a backbone molecule 
through primarily oxygenation reactions, makes them particularly valuable for synthetic 
biology applications. For instance, soluble bacterial P450s have been engineered to oxidise 
diverse chemical scaffolds for the production of high value chemicals, highlighting the 
malleability as well as robustness of these proteins (Girvan and Munro, 2016). 
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 Artificial protein scaffolding is another versatile approach (Fig. 2, see protein 
engineering box), that allows mimicking of natural machineries for multi-enzyme pathways, 
and has been extensively applied in synthetic biology. Generally in nature multi-cascade 
reactions occur in multi-enzyme complexes where micro-compartments facilitate individual 
reactions. This phenomenon known as metabolon formation or metabolic channelling allows 
avoidance of flux imbalances, diffusion and loss of intermediates, release of toxic pathway 
intermediates, and interference from competing metabolic networks (Bassard et al., 2017; 
Jørgensen et al., 2005). Therefore, the assembly of active centres of sequential pathway 
enzymes in close proximity is of great interest to increase overall catalytic efficiency of a 
heterologous pathway (Conrado et al., 2008). In this phenomenon of metabolic channelling, 
enzymes are ordered sequentially to ensure that the local concentration of pathway 
intermediates is high around the enzyme complex. As most plant specialised metabolite 
biosynthetic pathways involve multiple enzymes, metabolic channelling in production hosts 
may well be an effective means of optimising production and increasing titres (Singleton et 
al., 2014). A variety of target molecules have been synthesised through the scaffolding of 
enzymes with peptide motifs and their cognate adaptor domains (Horn and Sticht, 2015; 
Proschel et al., 2015). In E. coli scaffolding has been effectively used for the increased 
production of glucaric acid (Moon et al., 2010) and mevalonate, the precursor of sesqui- and 
triterpenoids (Dueber et al., 2009). Similarly, in yeast resveratrol production was enhanced by 
the scaffolding of 4-coumarate:CoA ligase and stilbene synthase (Wang and Yu, 2012). 
Artificial scaffolding additionally offers the possibility of evaluating the effect of different 
enzyme ratios on product yield. For instance, the titre of glucaric acid produced in E. coli was 
more strongly affected by inclusion of scaffold interaction domains for the upstream enzymes, 
than for the later enzymes of the pathway (Moon et al., 2010). 
Like artificial scaffolding, the direct fusion of proteins has also been used to improve 
catalytic efficiency of enzymes. In nature for instance, the natural fusion of a P450 to an aldo-
keto reductase in Papaver spp. was discovered to be essential for the synthesis of morphinan 
alkaloids (Farrow et al., 2015; Winzer et al., 2015). Artificial fusion of the Panax ginseng 
P450 protopanaxadiol synthase (PPDS) and the Arabidopsis thaliana P450 reductase ATR1 
was shown to improve catalytic activity of the PPDS (Zhao et al., 2016). Likewise, the in-
frame fusion of a red clover P450 isoflavonone synthase with a rice P450 reductase after the 
removal of the membrane binding domains enabled the conversion of naringenin to genistein 
in E. coli (Kim et al., 2009).  
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Biosensors 
The quantification of plant natural products in a production host is often challenging, as they 
are seldom associated with a measurable phenotype. However, natural biological regulators 
can serve as molecular reporters in the presence of specific ligands, and they can be applied as 
biosensors to correlate the amount of ligand to the read out of a reporter protein. Typically 
biosensors are linked to a colorimetric output to report the concentration of metabolites. This 
enables the screening and selection of better performing strains in a high-throughput fashion. 
Fluorescent reporter proteins are broadly employed because of their compatibility with 
fluorescence-activated cell sorting (FACS), which allows for efficient screening in a short 
time (Binder et al., 2012). The transcriptional regulators in bacteria that activate metabolite 
degradation and carbon assimilation pathways upon detection of plant flavonoids, are 
naturally existing regulatory mechanisms that can be applied as biosensors (Hirooka and 
Fujita, 2011; Marin et al., 2013; Rao and Cooper, 1994). By combining such transcription 
factors with a fluorescent reporter signal, flavonoid biosensors for the quantification of 
naringenin, quercetin and kaempferol were successfully constructed in E. coli (Siedler et al., 
2014). Small molecule sensors can also be coupled to a selective advantage, so as to transform 
biosynthetic phenotypes into a fitness difference. Raman and co-workers used a sensor 
domain responsive to a target molecule, to control the expression of a reporter gene necessary 
for the survival of the strain under selective conditions. By converting the intracellular 
presence of the target molecule into a fitness advantage, a general strategy was developed for 
the enrichment of rare high producers within a population of variants. Using this approach the 
production of naringenin and glucaric acid in E. coli was improved significantly through 
evolution guided pathway optimisation (Raman et al., 2014). In a more recent study, the use 
of ligand binding domains was proposed as a general strategy to construct small molecule 
biosensors for any target molecule. Feng and co-workers converted a single high-affinity 
ligand binding domain into multiple specific conditionally-stable scaffolds, which when fused 
to transcription factors generated biosensors that respond to their target ligands, the steroids 
digoxin and progesterone (Feng et al., 2015). 
Natural biosensors are ubiquitous detectors that perceive intra- or extracellular 
environmental signals like small molecules, ions, or physical parameters. They respond to 
detected signals by modifying cellular activity at a transcriptional, translational, or protein 
activity level. For instance, E. coli has 230 metabolite responsive transcription factors that 
sense and respond to sugars and their phosphates, amino acids and lipids (Binder et al., 2012). 
The ability of biosensors to switch between an ‘on and off’ status in response to stimuli, 
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makes them applicable for various synthetic biology purposes. Biosensors that can sense and 
respond to small molecule stimuli within cells have a wide range of applications, including 
regulation and optimisation of metabolic pathways, measurement and imaging of metabolite 
concentration, and monitoring of environmental toxins (Hassani et al., 2016; Mehrotra, 2016; 
Paige et al., 2012; Raman et al., 2014; Rogers et al., 2016; Zhang et al., 2012; Zhang and 
Keasling, 2011). There are several control elements within a cell that can modulate gene 
expression in response to a stimulus and therefore can be employed as biosensors, including 
transcriptional regulatory proteins, RNA based genetic riboswitch regulators, and functional 
enzymes (De Paepe et al., 2016; Mehdizadeh Aghdam et al., 2016; Palchetti, 2016). 
Transcription factors play a key role in biosensor design as they can be easily incorporated 
into synthetic circuits to control gene expression conditionally. Transcription factor based 
regulatory biosensors are particularly attractive due to the modularity of their constituent 
parts, the DNA binding domain/promoter pair, the ligand binding domain, the transcription 
activation domain, the reporter and the host strain, all of which can be modified according to 
the application (De Paepe et al., 2016; Mahr and Frunzke, 2016). 
In a distinct approach, rather than using fluorescent protein production as the output, 
an enzyme-coupled biosensor was developed in yeast to identify a tyrosine hydroxylase that 
could efficiently convert L-tyrosine to L-3,4-dihydroxyphenylalanine (L-DOPA), a pathway 
intermediate in the synthesis of benzylisoquinoline alkaloids (BIA). For this a plant 
biosynthetic enzyme that converts L-DOPA to a yellow fluorescent pigment was introduced 
into S. cerevisiae as a simple quantifiable biosensor read out. Using this biosensor an efficient 
tyrosine hydroxylase was identified from a mutant library of tyrosine hydroxylases, and used 
to synthesise the BIA intermediates (S)-reticuline and (S)-norcoclaurine from glucose in yeast 
(DeLoache and Russ, 2015). 
Biosensors are an attractive phenotype screening platform, with promising design 
strategies that make their applicability in industrial processes a reality for the future. For 
instance, biosensors have been successfully used for the real-time monitoring of metabolite 
production (Rogers and Church, 2016), and multiple biosynthetic components have been 
screened in a chassis using multiple robust sensors that have low false positive rates and wide 
operational ranges (Rogers et al., 2015). The lack of sensor domains for all industrially 
valuable compounds, makes biosensor directed metabolic engineering in production hosts 
challenging. However, further characterisation of biosensor systems and protein engineering 
is expected to help address these concerns and provide solutions for the field. 
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Minimal genomes 
The natural variation in genome sizes across species has raised questions about the size of 
minimal genomes and the essential set of genes required for maintaining cellular life (Glass et 
al., 2006). Through gene deletion approaches, researchers have generated smaller and 
increasingly stable bacterial genomes showing that a large proportion of the genomes can be 
readily deleted without affecting growth and survival of the cells. In E. coli over 15% genome 
reduction was achieved by deleting transposable elements and horizontally derived genes 
without significantly affecting growth (Csorgo et al., 2012; Mizoguchi et al., 2007; 
Umenhoffer et al., 2010). Likewise genome reductions have also been achieved in 
Schizosaccharomyces pombe and B. subtilis (Ara et al., 2007; Giga-Hama et al., 2007). 
 Microbial production chassis during evolution have accumulated many genes other 
than those essential for growth and survival, to endure ever-changing environmental 
challenges. Amongst these are genes that are non-essential or even harmful for the industrial 
production of compounds with commercial value, like the genes that encode for enzymes that 
degrade the desired product or genes that code for biosynthetic pathways of undesired 
products which make downstream isolation of the desired compound demanding (Fujio, 
2007). Production chassis with minimal genomes where the unnecessary and harmful genes 
are deleted, thus prove to be ideal for industrial production of commercially valuable 
compounds. The industrial actinobacteria Streptomyces avermitilis, with its endogenous 
specialized metabolism deleted, serves as an efficient production host for the expression of 
exogenous biosynthetic genes. Through the expression of a codon-optimised amorpha-4,11-
diene synthase, the production of amorpha-4,11-diene was achieved in the genome-minimised 
strain of S. avermitilis optimised for terpenoid production (Komatsu et al., 2010). 
 Similarly, a genome reduced strain of S. cerevisiae is being generated by an 
international consortium of researchers under the Sc2.0 project (http://syntheticyeast.org/sc2-
0/). The designer chromosome SynIII, which has approximately one-sixth of the base pairs of 
the wild-type chromosome III, was the first to be successfully generated and yeast cells 
carrying either of the two chromosomes were phenotypically indistinguishable (Annaluru et 
al., 2014). More recently, the consortium reported a highly modified strain with the genome 
reduced in size by nearly 8% (Richardson et al., 2017). The genome reduced yeast strain 
would be an ideal host for the introduction of large biosynthetic pathways, like that of the 
alkaloids, for the production of multi-gene plant natural product pathways. 
 
Perspective 
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An ever increasing number of tools and strategies are being developed and applied to engineer 
and optimise the challenges faced for the production of high-value specialised metabolites in 
unicellular hosts. Advances in synthetic biology tools, development of high throughput 
computational engineering approaches and discovery of new molecular biology phenomena 
improve our ability to refactor biosynthetic pathways to meet the global demand for valuable 
natural products. The broadening of synthetic biology hosts from the canonical ones to others 
based on the biotechnological application sought, has allowed the identification of key 
features that make a good chassis. These primarily include a convenient lifestyle, rapid 
growth, well characterised regulatory elements and engineering tools, useful interactions with 
the environment and an accurate map of the hosts’ metabolic network. In addition there is a 
need for reliable prediction of the physiological status of the chassis using metabolic models, 
whilst considering resource availability and investment versus product output. The dynamic 
description of cells and the available toolkits therefore form an integral part of efficiently 
engineering smart cell factories of the future. Although the metabolic capacities of unicellular 
hosts form the basis for many biotechnological advances, there are limits to what can be 
achieved with single strains. There is growing focus on the metabolic potential of microbial 
consortia to perform complex processes that are inefficient or impossible with a single 
species. This realisation of the potential of synthetic ecologies, necessitates better 
understanding of the key components that influence stable coexistence of multiple organisms 
(Escalante et al., 2015). Incorporating evolutionary and ecological perspectives into the 
design of microbial consortia is further relevant to achieve stable and sustainable systems. 
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Figure Legends 
Figure 1: Schematic representation of the cyclical synthetic biology workflow for metabolic 
engineering. The workflow is standardised regardless of the DNA components or the host 
organism, and progresses through iterative cycles of the Design-Build-Test-Learn process to 
achieve predictable Outputs. In the Design phase, the engineer defines the goal, identifies the 
pathway(s) and gene(s) of interest, selects host-specific regulatory components (parts) that 
enable the desired expression of transgene(s), and opts for an assembly approach. The design 
is implemented in the Build phase and introduced into the host. Evaluating the engineered 
strains for performance of parts (transcripts and proteins) and production of target molecule(s) 
generates Test data, which is used during the Learn phase to analyse the components, 
providing an opportunity to deconstruct complex part combinations and generate knowledge, 
which can be used for production of tangible and predictable Output(s).  
 
Figure 2: A schematic overview of the latest synthetic biology tools available for engineering 
high value plant natural products in unicellular industrial hosts. For each emerging tool, the 
basic design principles behind a selection of strategies are depicted. 
 
Figure 3: A concise flow diagram depicting the key steps in engineering unicellular chassis 
for the production of high value plant natural products. 
 
Figure 4: A visual guide to the key features to consider for chassis selection for the 
engineering and production of plant natural products in heterologous hosts. 
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Table 1: Examples of metabolite production systems in cyanobacteria and microalgae 
 
Host Compound Reference Heterologous 
(H) / 
Endogenous 
(E) pathway 
Considerations for engineering of chassis 
organism 
Cyanobacteria     
Synechococcus 
sp. PCC 7942 
2,3-Butanediol Oliver et al. 2013 H Doubling time 12–24 hours. Autotrophic 
metabolism. Genetic manipulation via homologous 
recombination (HR) allows targeted engineering. 
Genome-scale metabolic model available (Berla et 
al., 2013). 
 
Isobutaraldehyde Atsumi et al. 2009 H 
Sucrose Ducat et al. 2012 H 
Isoprene Gao et al. 2016 H 
Isobutanol Atsumi et al. 2009 H 
2-Methyl-1-butanol Shen and Liao 2012 H 
Lactate Angermayr et al. 2014 H 
1,2-Propanediol  Li and Liao 2013 H 
Synechococcus  
sp. PCC 7002 
Limonene  Davies et al. 2014 H Doubling time 3.5 hours. Mixotrophic and 
autotrophic metabolism. Genetic manipulation via 
HR possible. Genome-scale metabolic model 
available (Berla et al., 2013). 
Bisabolene Davies et al. 2014 H 
Synechocystis  
sp. PCC 6803 
Ethanol Gao et al. 2011 H Doubling time 6–12 hours. Mixotrophic and 
autotrophic metabolism. Genetic manipulation via 
HR possible. Genome-scale metabolic model 
available (Berla et al., 2013). 
3-Hydroxypropionate Lan et al. 2015 H 
Ethylene Xiong et al. 2015 H 
Isobutanol Varman et al. 2013 H 
3-Hydroxybutyrate Wang et al. 2013a H 
Heptadecane Wang et al. 2013b H 
Mannitol Jacobsen and Frigaard 2014 H 
     
     
Microalgae     
Chlamydomonas 
reinhardtii 
Hydrogen* Li et al. 2010 E Doubling time 5-8 hours. Both autotrophic and 
mixotrophic growth possible. Genomes of nucleus, 
chloroplast and mitochondrion sequenced and 
highly annotated. Transformation of all genomes 
routine. Comprehensive genetic, molecular and 
genomic resources available. Genome editting 
only possible through direct delivery of Cas9 
ribonucleoprotein (RNP). Some limited knowledge 
of scale-up in bioreactors. Genome-scale 
metabolic model available. 
Lipids Deng et al. 2012 E 
Carotenoids Couso et al. 2011 H 
 Cordero et al. 2011 H 
Phaeodactylum 
tricornutum 
Lipids Xue et al. 2015 E Doubling time 18-29 hours. Genome sequenced 
and annotated. Nuclear genome can be 
transformed, also introduction of episomes by 
conjugation. Molecular tools expanding rapidly, 
and amiRNA and CRISPR/Cas9 genome editing 
established. 
 Peng et al. 2014  E 
Enhanced FA profile Gong et al. 2011 E 
 Hamilton et al. 2014 H 
Thalassiosira 
pseudonana 
Lipids Trentacoste et al. 2013 E Doubling time ~24 hours. Genome sequenced. 
Nuclear genome can be transformed routinely. 
Molecular tools expanding rapidly, including 
amiRNA. CRISPR/Cas9 genome editing reported. 
Ribose sensor Marshall et al. 2012 H 
Chlorella 
zofigiensis 
Carotenoids Liu et al. 2010 E Can grow rapidly in phototrophic, heterotrophic 
and mixotrophic conditions and naturally 
accumulates carotenoids, including astaxanthin, 
thus ideal for large-scale cultivation. 
Transformation reported. 
Chlorella  
minutissima 
Lipids Hsieh et al. 2012 E Transformation by HR reported. 
Chlorella  
ellipsoidea 
Lipids Zhang et al. 2014 H Fast growth under autotrophic or heterotrophic 
conditions. Transformation reported. Use of plant 
promoter/terminators demonstrated. 
Haematococcus 
pluvialis 
Carotenoids Steinbrenner and Sandmann, 
2006 
E Doubling time 13-72 hours. Naturally accumulates 
carotenoids, including astaxanthin, and being 
employed in large-scale cultivation. Molecular, 
genetic and genomic resources are very limited.  
Asterisk indicates trait engineering via the chloroplast genome. 
